Cancer has always been a worldwide problem, and the application of radiotherapy has
greatly improved the survival rate of cancer patients. Radiotherapy can modulate multiple …

Objective Stereotactic body radiation therapy is the preferred treatment modality for patients
with inoperable early-stage non–small cell lung cancer. However, comparative outcomes …

Objective The lower airway bacterial microbiome influences carcinogenesis and response to
immunotherapy in non–small cell lung cancer (NSCLC). We investigated the association of …

Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …

Non-small cell lung cancer (NSCLC) is of major concern for society as it is associated with
high mortality and is one of the most commonly occurring of all cancers. Due to the number …

Purpose Some recent studies have suggested a relationship between cardiac dose and
mortality in non-small cell lung cancer (NSCLC), but others have reported conflicting data …

The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing
population and introduction of screening for high-risk individuals. Optimal management …

Stereotactic ablative body radiotherapy (SABR) describes a radiotherapy (RT) technique
where high doses of radiation are precisely delivered to an extracranial target within the …

Whether stereotactic ablative radiotherapy (SABR) is comparable to surgery in treating stage
I non-small-cell lung cancer (NSCLC) is unknown. Therefore, we conducted this meta …

Selpercatinib, a first-in-class, highly selective and potent central nervous system-active RET
kinase inhibitor demonstrated clinically meaningful activity with manageable toxicity in …